[Inhalation therapy with the new antisecretory drug ambroxol (metabolite VIII of bromhexine) in otorhinolaryngology].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000551:Ambroxol / Q000008:administration & dosage / Q000627:therapeutic use*; D001964:Bromhexine / Q000031:analogs & derivatives*; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D008875:Middle Aged; D010036:Otolaryngology; D012138:Respiratory Therapy; D012140:Respiratory Tract Diseases / Q000188:drug therapy*
D000551:Ambroxol; D001964:Bromhexine
Inhalationstherapie mit dem neuen Sekretolytikum Ambroxol (Metabolit VIII des Bromhexin) in der Hals-Nasen-Ohren-Praxis.